Health Invest Partners Ab Cabaletta Bio, Inc. Transaction History
Health Invest Partners Ab
- $208 Million
- Q4 2024
A detailed history of Health Invest Partners Ab transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Health Invest Partners Ab holds 247,454 shares of CABA stock, worth $447,891. This represents 0.26% of its overall portfolio holdings.
Number of Shares
247,454
Previous 168,522
46.84%
Holding current value
$447,891
Previous $795,000
31.57%
% of portfolio
0.26%
Previous 0.39%
Shares
5 transactions
Others Institutions Holding CABA
# of Institutions
115Shares Held
39.6MCall Options Held
297KPut Options Held
98.6K-
Black Rock Inc. New York, NY4.76MShares$8.61 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.07MShares$7.37 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.63MShares$6.58 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.87MShares$5.19 Million0.0% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA2.76MShares$5 Million1.64% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $52.5M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...